a public good project by the
Synthesis
Company
of California

© 2026

Swayam Prakash Srivastava | doi.page

0 works0 citations0 h-index

Swayam Prakash Srivastava

University of Michigan(US)Yale University(US)

Publications by Year

Research Areas

Diabetes Treatment and Management, Chronic Kidney Disease and Diabetes, Natural Antidiabetic Agents Studies, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer

Most-Cited Works

→ Linagliptin-Mediated DPP-4 Inhibition Ameliorates Kidney Fibrosis in Streptozotocin-Induced Diabetic Mice by Inhibiting Endothelial-to-Mesenchymal Transition in a Therapeutic Regimen(2014)363 cited
→ Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules(2020)234 cited
→ SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis(2018)178 cited
→ Three-dimensional reconstruction of the 70S Escherichia coli ribosome in ice: the distribution of ribosomal RNA.(1991)168 cited
→ Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition(2015)154 cited
→ Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy(2021)150 cited

→ MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT(2013)

124 cited

→ miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells(2010)119 cited

→ Design and synthesis of 2,4-disubstituted polyhydroquinolines as prospective antihyperglycemic and lipid modulating agents(2009)103 cited

→ microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney(2019)99 cited